Acute effect of orlistat on post‐prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Aims Post‐prandial lipaemia is prolonged and exaggerated in patients with Type 2 diabetes mellitus, with an accumulation of atherogenic triglyceride‐rich lipoprotein remnants. We postulate that orlistat, a gastrointestinal lipase inhibitor, may cause changes in post‐prandial lipoprotein metabolism by reducing dietary triglyceride absorption. Methods The acute effect of a single dose of 120 mg orlistat on post‐prandial glucose, lipids, remnant lipoproteins and free fatty acids (FFA) was evaluated in a randomized, double‐blind, placebo‐controlled cross‐over study of 63 overweight patients with Type 2 diabetes mellitus (body mass index 30.4 ± 3.8 kg/m 2). Either a single dose of orlistat or placebo was given before a standard mixed meal containing 70 g of fat and plasma triglyceride (TG), remnant‐like particles cholesterol (RLP‐C) and FFA were sampled at 2‐h intervals for 8 h. RLP‐C was measured by an immunoseparation assay and FFA by an enzymatic colorimetric method. Results The concentrations of plasma TG (P < 0.0001), RLP‐C (P = 0.003), and FFA (P < 0.0001) were significantly lower at 2 h after orlistat compared with placebo. Both plasma RLP‐C (P = 0.04) and FFA (P < 0.0001) remained lower after orlistat than placebo at 4 h. The incremental area under the curve (iAUC) above baseline fasting level for both TG and RLP‐C was significantly more reduced after orlistat than placebo (iAUC‐TG 5.8 (3.7–8.2) mmol/l × h−1 vs. 5.7 (4.1–10.9), respectively, P = 0.04; iAUC‐RLP‐C: 0.53 (0.23–1.04) mmol/l × h−1 vs. 0.56 (0.35–1.40), respectively, P = 0.02). The test meal was well tolerated by all subjects, with only three subjects reporting faecal urgency after orlistat. Conclusions Orlistat has a beneficial effect on post‐prandial lipaemia in overweight Type 2 diabetic patients and lowers plasma TG, RLP‐C and FFA in the early post‐prandial period. Diabet. Med. 19, 944–948 (2002)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hollander, P. A., Elbein, S. C., Hirsch, I. B., Kelley, D., McGill, J., Taylor, T., Weiss, S. R., Crockett, S. E., Kaplan, R. A., Comstock, J., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1288 · Cited by 654
Postprandial lipoprotein metabolism and atherosclerosis.
Karpe, F. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00548.x · Cited by 360
Kugiyama, K., Doi, H., Takazoe, K., Kawano, H., Soejima, H., Mizuno, Y., Tsunoda, R., Sakamoto, T., Nakano, T., Nakajima, K., et al. (1999) · Circulation · doi:10.1161/01.cir.99.22.2858 · Cited by 284
Karpe, F., Boquist, S., Tang, R., Bond, G. M., de Faire, U., & Hamsten, A. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32331-2 · Cited by 174
Remnant lipoproteins as therapeutic targets
Havel, R. J. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200012000-00008 · Cited by 107
Cited by
Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus
Norris, S. L., Zhang, X., Avenell, A., Gregg, E., Schmid, C. H., & Lau, J. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004096.pub2 · Cited by 113
Eleftheriadou, I., Grigoropoulou, P., Katsilambros, N., & Tentolouris, N. (2008) · Current Diabetes Reviews · doi:10.2174/157339908786241133 · Cited by 55
“(2002) [115] evaluated in a randomized, double-blind, placebo-controlled study the acute effect of a single dose of 120 mg of orlistat on postprandial lipids, remnant lipoproteins and FFAs in overweight patients with type 2 DM.”
MethodNakou, E. S., Filippatos, T. D., Agouridis, A. P., Kostara, C., Bairaktari, E. T., & Elisaf, M. S. (2010) · Lipids · doi:10.1007/s11745-010-3409-0 · Cited by 23
The role of anti-obesity medication in prevention of diabetes and its complications
Oh, T. J. (2019) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes.2019.28.3.158 · Cited by 19
Metadata
- Authors
- Tan, K. C. B., Tso, A. W. K., Tam, S. C. F., Pang, R. W. C., & Lam, K. S. L.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2002-11
- Volume
- 19
- Issue
- 11
- Pages
- 944-948
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2053114173
- Cited by
- 41
- References
- 5
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acute effect of orlistat on post‐prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus. https://app.cochat.ai/papers/10.1046/j.1464-5491.2002.00823.x
- The paper
- Tan, K. C. B., Tso, A. W. K., Tam, S. C. F., Pang, R. W. C., & Lam, K. S. L. (2002). Acute effect of orlistat on post‐prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus. Diabetic Medicine. https://doi.org/10.1046/j.1464-5491.2002.00823.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.